These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33101023)

  • 1. Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19).
    Verma S; Twilley D; Esmear T; Oosthuizen CB; Reid AM; Nel M; Lall N
    Front Pharmacol; 2020; 11():561334. PubMed ID: 33101023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics.
    Abdallah HM; El-Halawany AM; Darwish KM; Algandaby MM; Mohamed GA; Ibrahim SRM; Koshak AE; Elhady SS; Fadil SA; Alqarni AA; Abdel-Naim AB; Elfaky MA
    Plants (Basel); 2022 Jul; 11(15):. PubMed ID: 35893619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.
    Jamshidnia M; Sewell RDE; Rafieian-Kopaei M
    Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective.
    Aggarwal V; Bala E; Kumar P; Raizada P; Singh P; Verma PK
    Curr Top Med Chem; 2023; 23(17):1664-1698. PubMed ID: 36974409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro.
    Ngwe Tun MM; Toume K; Luvai E; Nwe KM; Mizukami S; Hirayama K; Komatsu K; Morita K
    J Nat Med; 2022 Mar; 76(2):402-409. PubMed ID: 35006524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
    Zhao J; Zhang G; Zhang Y; Yi D; Li Q; Ma L; Guo S; Li X; Guo F; Lin R; Luu G; Liu Z; Wang Y; Cen S
    Antiviral Res; 2021 Dec; 196():105209. PubMed ID: 34801588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective inhibition of HCoV-OC43 and SARS-CoV-2 by phytochemicals in vitro and in vivo.
    Ojha D; Jessop F; Bosio CM; Peterson KE
    Int J Antimicrob Agents; 2023 Sep; 62(3):106893. PubMed ID: 37339711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting natural products against SARS-CoV-2.
    Al-Harrasi A; Behl T; Upadhyay T; Chigurupati S; Bhatt S; Sehgal A; Bhatia S; Singh S; Sharma N; Vijayabalan S; Palanimuthu VR; Das S; Kaur R; Aleya L; Bungau S
    Environ Sci Pollut Res Int; 2022 Jun; 29(28):42404-42432. PubMed ID: 35362883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal Plants as Sources of Active Molecules Against COVID-19.
    Benarba B; Pandiella A
    Front Pharmacol; 2020; 11():1189. PubMed ID: 32848790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents.
    Kim CH
    Front Pharmacol; 2021; 12():590509. PubMed ID: 34122058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus.
    Josset L; Menachery VD; Gralinski LE; Agnihothram S; Sova P; Carter VS; Yount BL; Graham RL; Baric RS; Katze MG
    mBio; 2013 Apr; 4(3):e00165-13. PubMed ID: 23631916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
    Kaur R; Tada T; Landau NR
    mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.
    Prasansuklab A; Theerasri A; Rangsinth P; Sillapachaiyaporn C; Chuchawankul S; Tencomnao T
    J Tradit Complement Med; 2021 Mar; 11(2):144-157. PubMed ID: 33520683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
    Jamwal S; Gautam A; Elsworth J; Kumar M; Chawla R; Kumar P
    Life Sci; 2020 Sep; 257():118105. PubMed ID: 32687917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19.
    Raihan T; Rabbee MF; Roy P; Choudhury S; Baek KH; Azad AK
    Front Mol Biosci; 2021; 8():732256. PubMed ID: 34557521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic.
    Bhuiyan FR; Howlader S; Raihan T; Hasan M
    Front Med (Lausanne); 2020; 7():444. PubMed ID: 32850918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.